3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.77%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-22.70%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-59.22%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-58.79%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-62.10%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-62.07%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-62.07%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.81%
Dividend reduction while MZX.DE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
197.33%
Positive OCF growth while MZX.DE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
287.89%
FCF growth above 1.5x MZX.DE's 81.32%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.73%
3Y revenue/share CAGR at 50-75% of MZX.DE's 13.28%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-81.49%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
75.09%
3Y equity/share CAGR above 1.5x MZX.DE's 46.84%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-83.30%
Negative near-term dividend growth while MZX.DE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-17.68%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-3.26%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.30%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
2.91%
Under 50% of MZX.DE's 403.08%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.83%
We’re deleveraging while MZX.DE stands at 2.61%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-5.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.